Risk assessment of over-the-counter cannabinoid-based cosmetics: Legal and regulatory issues governing the safety of cannabinoid-based cosmetics in the UAE

Necopidem
Clinical data
ATC code
  • none
Identifiers
  • N-([2-(4-ethylphenyl)-6-methylimidazo[1,2-a]pyridin-3-yl]methyl)-N,3-dimethylbutanamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H29N3O
Molar mass363.505 g·mol−1
3D model (JSmol)
  • O=C(N(C)Cc1c(nc2ccc(cn12)C)c3ccc(cc3)CC)CC(C)C
  • InChI=1S/C23H29N3O/c1-6-18-8-10-19(11-9-18)23-20(15-25(5)22(27)13-16(2)3)26-14-17(4)7-12-21(26)24-23/h7-12,14,16H,6,13,15H2,1-5H3 checkY
  • Key:YRMLUAGKHYADKJ-UHFFFAOYSA-N checkY
  (verify)

Necopidem is a drug in the imidazopyridine family, which is related to the better known drugs zolpidem and alpidem. It is therefore considered a nonbenzodiazepine and as such may have sedative and anxiolytic effects, given its structural similarity to other nonbenzodiazepine hypnotics.[1]

References

  1. ^ Duan GY, Zhang YJ, Hao BQ (November 2010). "Ethyl 8-(4-nitro-phen-yl)imidazo[1,2-a]pyridine-7-carboxyl-ate". Acta Crystallographica Section E. 66 (Pt 12): o3272. doi:10.1107/S1600536810047938. PMC 3011613. PMID 21589555.